FDA Registration and CE Marking of New Lateral Flow Immunoassay Reader, ADxLR5®
2016 AACC Annual Meeting Press ProgramAbingdon Health are pleased to announce the CE marking and FDA registration of their newly available immunoassay reader – ADxLR5® as a Class 1 Medical Device. The ADxLR5® lateral flow device reader has been developed as a next generation technology designed to offer the user the most up to date features required for rapid testing, including a touch screen user interface, barcode sample identification ,stored calibration curve processing and wifi or wired connectivity.